Literature DB >> 12678089

Pharmacogenetic interventions, orphan drugs, and distributive justice: the role of cost-benefit analysis.

Arti K Rai1.   

Abstract

Keywords:  Analytical Approach; Health Care and Public Health; Orphan Drug Act

Mesh：

Year:  2002        PMID： 12678089     DOI： 10.1017/s0265052502192107

Source DB:  PubMed          Journal:  Soc Philos Policy        ISSN： 0265-0525


× No keyword cloud information.
  5 in total

1.  Racializing drug design: implications of pharmacogenomics for health disparities.

Authors:  Sandra Soo-Jin Lee
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

Review 2.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

Review 3.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

4.  Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?

Authors:  R Rodriguez-Monguio; T Spargo; E Seoane-Vazquez
Journal:  Orphanet J Rare Dis       Date:  2017-01-05       Impact factor: 4.123

5.  What Is the Purpose of the Orphan Drug Act?

Authors:  Matthew Herder
Journal:  PLoS Med       Date:  2017-01-03       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.